Using AI to diagnose, manage and predict chronic respiratory diseases
21 November 201917:35 - 17:40
Speaker: Rex Tan Chief Technology Officer, Aevice Health
AEvice Health has developed an innovative wearable technology that uses artificial intelligence to diagnose, manage and predict chronic respiratory diseases. Its first product, The AireSone System, assists patients to achieve better asthma control and quality of life. The current approach to asthma diagnosis is highly subjective, particularly in young children. This is an arduous process that is not only costly but can also take up to years and endangering patient from inadequate treatment control plan. By streamlining the process of asthma diagnosis and treatment, AireSone reduces the overall healthcare costs, while maximising outcomes for patients.